Compugen's Com701 In Combination Demonstrates Preliminary Anti-Tumor Activity In Ovarian Cancer Patients
Compugen Ltd CGEN:
COMPUGEN'S COM701 (ANTI-PVRIG) IN DUAL AND TRIPLE COMBINATION DEMONSTRATES PRELIMINARY ANTI-TUMOR ACTIVITY AND IMMUNE ACTIVATION IN PLATINUM RESISTANT OVARIAN CANCER PATIENTS